Invitation, Sobis

Invitation: Sobi's Aspaveli® - 52-week Phase 3 VALIANT data in nephrology

Veröffentlicht: 07.08.2025 um 18:08 Uhr, prnewswire.co.uk

Swedish Orphan Biovitrum AB Sweden

View original content:https://www.prnewswire.co.uk/news-releases/invitation-sobis-aspaveli---52-week-phase-3-valiant-data-in-nephrology-302471733.html

en | boerse | 67930133 |